Analysis of Demographics, Clinicopathological Features, and Treatment Approaches for Oral Squamous Cell Carcinoma Patients at a Johannesburg Academic Hospital: A Five-Year Retrospective Study - Report - MDSpire

Analysis of Demographics, Clinicopathological Features, and Treatment Approaches for Oral Squamous Cell Carcinoma Patients at a Johannesburg Academic Hospital: A Five-Year Retrospective Study

  • By

  • Gal Feller

  • Daniel Mmereki

  • Faiza Mahomed

  • Razia AG Khammissa

  • Duvern Ramiah

  • November 22, 2025

  • 0 min

Share

Clinical Report: Analysis of Demographics and Treatment Approaches for OSCC

Overview

This study provides a comprehensive analysis of the demographics, clinicopathological features, and treatment approaches for oral squamous cell carcinoma (OSCC) patients at a Johannesburg academic hospital over five years. The findings highlight the significant burden of OSCC in South Africa, particularly among patients presenting with advanced disease.

Background

Oral squamous cell carcinoma (OSCC) is a major contributor to cancer morbidity and mortality, especially in low- and middle-income countries where risk factors such as tobacco and alcohol use are prevalent. In South Africa, the late-stage presentation of OSCC is common, leading to limited treatment options and poorer outcomes. Understanding the demographics and treatment approaches for OSCC is crucial for improving patient care and outcomes in this population.

Data Highlights

No numerical data available in the provided source.

Key Findings

  • OSCC accounts for over 90% of malignant oral cavity tumors globally.
  • Common risk factors include tobacco smoking, alcohol abuse, and poor oral hygiene.
  • Many patients present with inoperable, late-stage disease at CMJAH.
  • Radiotherapy is the primary treatment modality for advanced OSCC, often combined with chemotherapy.
  • There is a lack of local data on the demographic distribution and treatment strategies for OSCC in South Africa.

Clinical Implications

Healthcare professionals should be aware of the high incidence of late-stage OSCC in South Africa and the associated treatment challenges. Enhanced screening and early detection strategies are essential to improve patient outcomes. Additionally, understanding the demographic and clinicopathological characteristics can inform tailored treatment approaches.

Conclusion

The study underscores the urgent need for improved data collection and treatment strategies for OSCC patients in South Africa, particularly in addressing the challenges posed by late-stage presentations. Continued research and awareness are vital for enhancing patient care in this population.

References

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), 2026 -- Head and Neck Cancer
  6. FDA approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma | FDA
  7. Prognostic Factors in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis - PubMed
  8. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
  9. FDA approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma | FDA
  10. Prognostic Factors in Oral Squamous Cell Carcinoma: Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Related Content